Can Two Toolkits Make a Sustainable Business?
Executive Summary
Things went downhill for population genetics company Gemini Genomics PLC after its IPO in July 2000, the most successful public offering of a UK company that year. Less than twelve months after raising $97 million on Nasdaq (where it hoped for greater visibility than from a London listing, given the paucity of UK genomics companies), the company has been bought by the German-American Sequenom Inc., in an all-paper deal worth about $224 million . Taking into account Gemini's net assets of $81.4 million, this values its technology at less than $150 million, a far cry from the company's $450 million market capitalization at its IPO.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.